Summarized Segment Financial Information |
Summarized segment financial information was as follows: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | (In millions) | | Evernorth | | Cigna Healthcare | | Other Operations | | Corporate and Eliminations | | Total | Three months ended June 30, 2022 | Revenues from external customers | | $ | 33,716 | | | $ | 10,622 | | | $ | 817 | | | $ | — | | | $ | 45,155 | | Intersegment revenues | | 1,131 | | | 586 | | | — | | | (1,717) | | | | Net investment income | | 16 | | | 178 | | | 131 | | | — | | | 325 | | Total revenues | | 34,863 | | | 11,386 | | | 948 | | | (1,717) | | | 45,480 | | | | | | | | | | | | | Net realized investment results from certain equity method investments | | — | | | (49) | | | — | | | — | | | (49) | | | | | | | | | | | | | Adjusted revenues | | $ | 34,863 | | | $ | 11,337 | | | $ | 948 | | | $ | (1,717) | | | $ | 45,431 | | Income (loss) before income taxes | | $ | 1,044 | | | $ | 1,205 | | | $ | 167 | | | $ | (431) | | | $ | 1,985 | | Pre-tax adjustments to reconcile to adjusted income from operations | | | | | | | | | | | | | | | | | | | | | | (Income) attributable to noncontrolling interests | | (13) | | | — | | | (2) | | | — | | | (15) | | Net realized investment (gains) losses (1) | | — | | | (22) | | | 68 | | | — | | | 46 | | Amortization of acquired intangible assets | | 444 | | | 57 | | | — | | | — | | | 501 | | Special items | | | | | | | | | | | Integration and transaction-related costs | | — | | | — | | | — | | | 36 | | | 36 | | Charge for organizational efficiency plan | | — | | | — | | | — | | | 22 | | | 22 | | Charges (benefits) associated with litigation matters | | — | | | — | | | — | | | (28) | | | (28) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Pre-tax adjusted income (loss) from operations | | $ | 1,475 | | | $ | 1,240 | | | $ | 233 | | | $ | (401) | | | $ | 2,547 | | | | | | | | | | | | | (In millions) | | Evernorth | | Cigna Healthcare | | Other Operations | | Corporate and Eliminations | | Total | Three months ended June 30, 2021 | Revenues from external customers | | $ | 31,553 | | | $ | 10,403 | | | $ | 865 | | | $ | — | | | $ | 42,821 | | Intersegment revenues | | 1,034 | | | 590 | | | — | | | (1,624) | | | | Net investment income | | 5 | | | 180 | | | 125 | | | — | | | 310 | | Total revenues | | 32,592 | | | 11,173 | | | 990 | | | (1,624) | | | 43,131 | | Net realized investment results from certain equity method investments | | — | | | (24) | | | — | | | — | | | (24) | | | | | | | | | | | | | Adjusted revenues | | $ | 32,592 | | | $ | 11,149 | | | $ | 990 | | | $ | (1,624) | | | $ | 43,107 | | Income (loss) before income taxes | | $ | 929 | | | $ | 1,111 | | | $ | 228 | | | $ | (370) | | | $ | 1,898 | | Pre-tax adjustments to reconcile to adjusted income from operations | | | | | | | | | | | (Income) attributable to noncontrolling interests | | (6) | | | — | | | (5) | | | — | | | (11) | | Net realized investment (gains) losses (1) | | 2 | | | (74) | | | (11) | | | — | | | (83) | | Amortization of acquired intangible assets | | 488 | | | 12 | | | 3 | | | — | | | 503 | | Special items | | | | | | | | | | | Integration and transaction-related costs | | — | | | — | | | — | | | 16 | | | 16 | | | | | | | | | | | | | | | | | | | | | | | | Debt extinguishment costs | | — | | | — | | | — | | | 10 | | | 10 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Pre-tax adjusted income (loss) from operations | | $ | 1,413 | | | $ | 1,049 | | | $ | 215 | | | $ | (344) | | | $ | 2,333 | |
(1) Includes the Company's share of certain realized investment results of its joint ventures reported in the Cigna Healthcare segment using the equity method of accounting. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | (In millions) | | Evernorth | | Cigna Healthcare | | Other Operations | | Corporate and Eliminations | | Total | Six months ended June 30, 2022 | Revenues from external customers | | $ | 66,005 | | | $ | 21,083 | | | $ | 1,658 | | | $ | — | | | $ | 88,746 | | Intersegment revenues | | 2,418 | | | 1,148 | | | — | | | (3,566) | | | | Net investment income | | 26 | | | 444 | | | 269 | | | — | | | 739 | | Total revenues | | 68,449 | | | 22,675 | | | 1,927 | | | (3,566) | | | 89,485 | | Net realized investment results from certain equity method investments | | — | | | 54 | | | — | | | — | | | 54 | | | | | | | | | | | | | Adjusted revenues | | $ | 68,449 | | | $ | 22,729 | | | $ | 1,927 | | | $ | (3,566) | | | $ | 89,539 | | | | | | | | | | | | | Income (loss) before income taxes | | $ | 1,914 | | | $ | 2,064 | | | $ | 382 | | | $ | (826) | | | $ | 3,534 | | Pre-tax adjustments to reconcile to adjusted income from operations | | | | | | | | | | | (Income) attributable to noncontrolling interests | | (24) | | | (1) | | | (7) | | | — | | | (32) | | Net realized investment (gains) losses (1) | | — | | | 384 | | | 84 | | | — | | | 468 | | Amortization of acquired intangible assets | | 887 | | | 72 | | | — | | | — | | | 959 | | Special items | | | | | | | | | | | Integration and transaction-related costs | | — | | | — | | | — | | | 88 | | | 88 | | Charge for organizational efficiency plan | | — | | | — | | | — | | | 22 | | | 22 | | Charges (benefits) associated with litigation matters | | — | | | — | | | — | | | (28) | | | (28) | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Pre-tax adjusted income (loss) from operations | | $ | 2,777 | | | $ | 2,519 | | | $ | 459 | | | $ | (744) | | | $ | 5,011 | | | | | | | | | | | | | (In millions) | | Evernorth | | Cigna Healthcare | | Other Operations | | Corporate and Eliminations | | Total | Six months ended June 30, 2021 | Revenues from external customers | | $ | 60,972 | | | $ | 20,688 | | | $ | 1,741 | | | $ | — | | | $ | 83,401 | | Intersegment revenues | | 2,232 | | | 1,099 | | | — | | | (3,331) | | | | Net investment income | | 8 | | | 439 | | | 254 | | | — | | | 701 | | Total revenues | | 63,212 | | | 22,226 | | | 1,995 | | | (3,331) | | | 84,102 | | | | | | | | | | | | | Net realized investment results from certain equity method investments | | — | | | (10) | | | — | | | — | | | (10) | | | | | | | | | | | | | Adjusted revenues | | $ | 63,212 | | | $ | 22,216 | | | $ | 1,995 | | | $ | (3,331) | | | $ | 84,092 | | | | | | | | | | | | | Income (loss) before income taxes | | $ | 1,678 | | | $ | 2,156 | | | $ | 434 | | | $ | (857) | | | $ | 3,411 | | Pre-tax adjustments to reconcile to adjusted income from operations | | | | | | | | | | | (Income) attributable to noncontrolling interests | | (11) | | | (1) | | | (11) | | | — | | | (23) | | Net realized investment (gains) losses (1) | | 4 | | | (90) | | | 16 | | | — | | | (70) | | Amortization of acquired intangible assets | | 965 | | | 26 | | | 7 | | | — | | | 998 | | Special items | | | | | | | | | | | Integration and transaction-related costs | | — | | | — | | | — | | | 45 | | | 45 | | | | | | | | | | | | | Charges (benefits) associated with litigation matters | | — | | | — | | | — | | | (27) | | | (27) | | Debt extinguishment costs | | — | | | — | | | — | | | 141 | | | 141 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Pre-tax adjusted income (loss) from operations | | $ | 2,636 | | | $ | 2,091 | | | $ | 446 | | | $ | (698) | | | $ | 4,475 | | (1) Includes the Company's share of certain realized investment results of its joint ventures reported in the Cigna Healthcare segment using the equity method of accounting.
|
Revenue from External Customers |
Revenue from external customers includes Pharmacy revenues, Premiums and Fees and other revenues. The following table presents these revenues by product, premium and service type for the three and six months ended June 30, 2022 and 2021: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | | (In millions) | | 2022 | | 2021 | | 2022 | | 2021 | | | Products (Pharmacy revenues) (ASC 606) | | | | | | | | | | | Network revenues | | $ | 16,107 | | | $ | 16,166 | | | $ | 31,638 | | | $ | 31,304 | | | | Home delivery and specialty revenues | | 15,268 | | | 13,341 | | | 29,967 | | | 26,115 | | | | Other revenues | | 1,667 | | | 1,619 | | | 3,379 | | | 3,007 | | | | Intercompany eliminations | | (1,070) | | | (1,079) | | | (2,315) | | | (2,354) | | | | Total pharmacy revenues | | 31,972 | | | 30,047 | | | 62,669 | | | 58,072 | | | | Insurance premiums (ASC 944) | | | | | | | | | | | Cigna Healthcare | | | | | | | | | | | U.S. Commercial | | | | | | | | | | | Insured | | 3,771 | | | 3,578 | | | 7,491 | | | 7,101 | | | | Stop loss | | 1,344 | | | 1,194 | | | 2,669 | | | 2,388 | | | | Other | | 352 | | | 308 | | | 712 | | | 618 | | | | U.S. Government | | | | | | | | | | | Medicare Advantage | | 2,053 | | | 2,116 | | | 4,131 | | | 4,208 | | | | Medicare Part D | | 345 | | | 410 | | | 746 | | | 860 | | | | Other | | 1,038 | | | 1,227 | | | 1,978 | | | 2,365 | | | | International Health | | 712 | | | 633 | | | 1,414 | | | 1,274 | | | | Total Cigna Healthcare | | 9,615 | | | 9,466 | | | 19,141 | | | 18,814 | | | | International businesses held for sale | | 737 | | | 809 | | | 1,500 | | | 1,618 | | | | | | | | | | | | | | | Other | | 74 | | | 50 | | | 143 | | | 108 | | | | Intercompany eliminations | | — | | | (2) | | | (2) | | | (3) | | | | Total premiums | | 10,426 | | | 10,323 | | | 20,782 | | | 20,537 | | | | Services (Fees) (ASC 606) | | | | | | | | | | | | | | | | | | | | | | Evernorth | | 1,790 | | | 1,456 | | | 3,414 | | | 2,770 | | | | Cigna Healthcare | | 1,478 | | | 1,425 | | | 2,974 | | | 2,859 | | | | Other Operations | | 4 | | | 5 | | | 9 | | | 10 | | | | Other revenues | | 132 | | | 108 | | | 147 | | | 127 | | | | Intercompany eliminations | | (647) | | | (543) | | | (1,249) | | | (974) | | | | Total fees and other revenues | | 2,757 | | | 2,451 | | | 5,295 | | | 4,792 | | | | Total revenues from external customers | | $ | 45,155 | | | $ | 42,821 | | | $ | 88,746 | | | $ | 83,401 | | | |
|